Lenacapavir: A capsid inhibitor for HIV-1 treatment and prevention

De Clercq Erik; Y Zhang; Guangdi Li; Yelin Deng; Ricardo Khouri; Daniel Růžek; Ewelina Król; Li Tan

doi:10.1016/j.bcp.2025.117125

Related publications

Article2018

Pharmaceutical Approaches to HIV Treatment and Prevention

Burçin Yavuz, Jessica L. Morgan, Laura Showalter, Katti R Horng, Satya Dandekar, Carolina Herrera, Patricia J. LiWang, David Kaplan

Article2016

Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?

Carlo Contoreggi, George Chrousos, Michele Di Mascio

Article2021

Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors

Xujie Zhang, Lin Sun, Megan E. Meuser, Waleed A. Zalloum, Shujing Xu, Tianguang Huang, Srinivasulu Cherukupalli, Xiangyi Jiang, Xiao Ding, Yucen Tao, Dongwei Kang, De Clercq Erik, Christophe Pannecouque, Alexej Dick, Simon Cocklin, Xinyong Liu, Peng Zhan

Article2011

Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly

Jörg Votteler, Liane Neumann, Sabine Hahn, Friedrich Hahn, Pia Rauch, Kerstin Schmidt, Nicole Studtrucker, Sara M. Ø. Solbak, Torgils Fossen, Peter Henklein, David E. Ott, Gudrun Holland, Norbert Bannert, Ulrich Sigmar Schubert

Article2003

Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design

Didier Esquieu, Jean‐Marie Péloponèse, Sandrine Opi, Catherine Grégoire, Jean de Mareuil, Jennifer Watkins, Grant R. Campbell, Jean-Pierre Dunot, James N. Sturgis, Myriam Witvrouw, Christophe Pannecouque, De Clercq Erik, Mickaël Montembault, Giang Vo‐Thanh, Monique Villiéras, Valérie Fargeas, Jacques Lebreton, Erwann Loret